started · updated
Medical experts warn of risks from unsupervised GLP-1 weight-loss medication use
Medical experts and the Sociedade Brasileira de Pediatria (SBP) are issuing urgent warnings regarding the unsupervised use of GLP-1 receptor agonists, commonly known as weight-loss pens. The SBP specifically highlighted risks for children and adolescents, noting that improper use can lead to growth and development deficits, dehydration, electrolyte imbalances, muscle loss, acute pancreatitis, and gallbladder issues. Furthermore, using these medications for purely aesthetic purposes may trigger eating disorders like anorexia and bulimia, as well as anxiety and depression.
Specialists emphasize that these drugs are medical treatments for conditions like obesity and type 2 diabetes, not supplements. Unsupervised use, including self-adjusting doses or using products without sanitary registration from agencies like Anvisa, poses significant health risks. Experts also note that weight loss after age 40 requires a more complex approach involving hormonal, metabolic, and nutritional considerations.
To mitigate risks such as excessive muscle loss and micronutrient deficiencies, endocrinologists recommend prioritizing nutritional density. Suggested protein intake targets are approximately 1.2g/kg/day for healthy young individuals and 1.5g/kg/day for the elderly or those at risk of sarcopenia.
Entities
Agência Brasil · Agência Nacional de Vigilância Sanitária · Aline Pinho · Anvisa · Associação Brasileira para o Estudo da Obesidade e Síndrome Metabólica · Ferhat Çetin · Marcio Mancini · Ranbaxy Farmacêutica · Sociedade Brasileira de Endocrinologia e Metabologia · Sociedade Brasileira de Pediatria
Claims
What the coverage asserts, and how many sources carry each claim.
- [● 2 SOURCES] Recommended protein intake is 1.2g/kg/day for healthy young people and 1.5g/kg/day for the elderly or those at risk of sarcopenia. comandonoticia.com.br · grnews.com.br
- [● 13 SOURCES] Using these medications for aesthetic purposes can trigger eating disorders such as anorexia and bulimia, along with anxiety and depression. paraonline.com.br · www.leiaja.com · www.acessa.com · omatogrosso.com · leiaecocentral.com.br · +8 more
- [● 2 SOURCES] The medication's effect on appetite and stomach emptying can lead to insufficient protein and vitamin intake. comandonoticia.com.br · grnews.com.br
- [● 13 SOURCES] Risks of unsupervised use include growth and development deficits, dehydration, electrolyte disturbances, muscle loss, acute pancreatitis, and gallbladder issues. paraonline.com.br · www.leiaja.com · www.acessa.com · omatogrosso.com · leiaecocentral.com.br · +8 more
- [● 13 SOURCES] The Sociedade Brasileira de Pediatria (SBP) issued an alert regarding the use of GLP-1 receptor agonists by children and adolescents without medical supervision. paraonline.com.br · www.leiaja.com · www.acessa.com · omatogrosso.com · leiaecocentral.com.br · +8 more